<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02665286</url>
  </required_header>
  <id_info>
    <org_study_id>2015-5903</org_study_id>
    <nct_id>NCT02665286</nct_id>
  </id_info>
  <brief_title>Orphenadrine and Methocarbamol for LBP</brief_title>
  <official_title>Methocarbamol and Orphenadrine for Acute, Non-traumatic, Non-radicular Low Back Pain: A Randomized, Placebo Controlled, 3-armed Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low back pain is a common cause of visit to emergency department. It is not clear if skeletal
      muscle relaxants are of benefit for patients with acute low back pain. This is a randomized
      study to determine if skeletal muscle relaxants, when combined with naproxen, improve
      outcomes more than naproxen alone
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with acute, non-traumatic, non-radicular low back pain will be enrolled at the time
      of discharge from the emergency department. Participants will be followed by telephone one
      week and 3 months after the ED visit
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional impairment as measured on the Roland Morris Disability Questionnaire</measure>
    <time_frame>1 week</time_frame>
    <description>Improvement in Roland Morris Disability Questionnaire between baseline and 1 week</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Low back pain as report on the following ordinal scale: severe, moderate, mild, or none</measure>
    <time_frame>1 week</time_frame>
    <description>Moderate or severe LBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medications--Patient self report of medication use</measure>
    <time_frame>1 week</time_frame>
    <description>Use of medication for LBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Roland Morris Disability Questionnaire--a 24 item low back pain instrument</measure>
    <time_frame>3 months</time_frame>
    <description>Score on Roland Morris Disability Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Desirability--This is a patient-centered outcome that allows each individual to determine the desirability of the intervention</measure>
    <time_frame>1 week</time_frame>
    <description>Participant response to the following question: Do you want the same medication combination during a subsequent episode of LBP</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Naproxen 500mg po BID x 10 days #20 + Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Orphenadrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Naproxen 500mg po BID x 10 days #20 + Orphenadrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methocarbamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Naproxen 500mg po BID x 10 days #20 + Methocarbamol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Orphenadrine</intervention_name>
    <description>Orphenadrine 100mg PO BID x 7 days</description>
    <arm_group_label>Orphenadrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methocarbamol</intervention_name>
    <description>Methocarbamol 750mg 1-2 tabs po TID x 7 days</description>
    <arm_group_label>Methocarbamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naproxen</intervention_name>
    <description>Naproxen 500mg PO BID x 7 days</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Orphenadrine</arm_group_label>
    <arm_group_label>Methocarbamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1/2 of placebo packages will be dosed to match methocarbamol: 1-2 tabs po TID x 7days 1/2 of placebo packages will be dosed to match orphenadrine: 1 tab PO BID x 7 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  LBP duration &lt;= 2 weeks

          -  No trauma to low back within previous month

          -  No radicular symptoms

          -  No history of low back pain or history of only infrequent episodes

        Exclusion Criteria:

          -  Medication allergies or contra-indications

          -  Not available for follow-up

          -  Chronic pain syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin W Friedman, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Belinda Tavarez</last_name>
    <phone>718-920-6626</phone>
    <email>btavarez@montefiore.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belinda Tavarez</last_name>
      <phone>718-920-6626</phone>
      <email>btavarez@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Benjamin W Friedman, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2016</study_first_submitted>
  <study_first_submitted_qc>January 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2016</study_first_posted>
  <last_update_submitted>September 6, 2016</last_update_submitted>
  <last_update_submitted_qc>September 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naproxen</mesh_term>
    <mesh_term>Orphenadrine</mesh_term>
    <mesh_term>Methocarbamol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>April 30, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

